Profund Advisors LLC Exact Sciences Corp Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Profund Advisors LLC holds 48,869 shares of EXAS stock, worth $2.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

48,869

Previous 78,589 37.82%

Holding current value

$2.9 Million

Previous $3.32 Million 0.21%

% of portfolio

0.13%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $1.26 Million - $2.11 Million	-29,720 Reduced 37.82%	48,869 $3.33 Million
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $2.29 Million - $4.12 Million	55,459 Added 239.77%	78,589 $3.32 Million
Q1 2024 May 08, 2024	BUY	$56.27 - $73.77 $68,536 - $89,851	1,218 Added 5.56%	23,130 $1.6 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $192,004 - $246,165	3,251 Added 17.42%	21,912 $1.62 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $122,978 - $184,709	1,865 Added 11.1%	18,661 $1.27 Million
Q2 2023 Aug 10, 2023	SELL	$62.68 - $95.05 $197,442 - $299,407	-3,150 Reduced 15.79%	16,796 $1.58 Million
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $5,993 - $8,987	127 Added 0.64%	19,946 $1.35 Million
Q4 2022 Feb 02, 2023	BUY	$30.35 - $53.15 $15,933 - $27,903	525 Added 2.72%	19,819 $981,000
Q3 2022 Nov 04, 2022	SELL	$31.97 - $49.37 $25,831 - $39,890	-808 Reduced 4.02%	19,294 $627,000
Q2 2022 Aug 01, 2022	SELL	$35.61 - $76.23 $54,625 - $116,936	-1,534 Reduced 7.09%	20,102 $792,000
Q1 2022 May 10, 2022	SELL	$57.56 - $82.54 $118,516 - $169,949	-2,059 Reduced 8.69%	21,636 $1.51 Million
Q4 2021 Feb 08, 2022	SELL	$72.5 - $100.68 $303,557 - $421,547	-4,187 Reduced 15.02%	23,695 $1.84 Million
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $126,065 - $173,297	-1,397 Reduced 4.77%	27,882 $2.66 Million
Q2 2021 Aug 12, 2021	SELL	$93.66 - $139.27 $47,672 - $70,888	-509 Reduced 1.71%	29,279 $3.64 Million
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $305,180 - $405,816	-2,618 Reduced 8.08%	29,788 $3.93 Million
Q4 2020 Feb 09, 2021	BUY	$99.61 - $142.12 $448,045 - $639,255	4,498 Added 16.12%	32,406 $4.29 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $263,824 - $369,072	-3,618 Reduced 11.48%	27,908 $2.85 Million
Q2 2020 Aug 03, 2020	BUY	$55.75 - $92.75 $292,353 - $486,381	5,244 Added 19.95%	31,526 $2.74 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $363,271 - $1 Million	-9,585 Reduced 26.72%	26,282 $1.52 Million
Q4 2019 Feb 18, 2020	BUY	$77.66 - $99.74 $471,163 - $605,122	6,067 Added 20.36%	35,867 $3.32 Million
Q3 2019 Nov 12, 2019	SELL	$90.37 - $122.49 $181,734 - $246,327	-2,011 Reduced 6.32%	29,800 $2.69 Million
Q2 2019 Aug 13, 2019	SELL	$89.51 - $118.04 $288,938 - $381,033	-3,228 Reduced 9.21%	31,811 $3.76 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $79,024 - $123,037	1,275 Added 3.78%	35,039 $3.04 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $459,135 - $677,233	-8,193 Reduced 19.53%	33,764 $2.13 Million
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $198,520 - $331,346	4,111 Added 10.86%	41,957 $3.31 Million
Q2 2018 Aug 13, 2018	SELL	$37.84 - $69.96 $199,492 - $368,829	-5,272 Reduced 12.23%	37,846 $2.26 Million
Q1 2018 May 14, 2018	SELL	$39.82 - $57.53 $166,567 - $240,647	-4,183 Reduced 8.84%	43,118 $1.74 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $230,032 - $299,403	-4,948 Reduced 9.47%	47,301 $2.49 Million
Q3 2017 Nov 13, 2017	BUY	$37.05 - $47.12 $1.94 Million - $2.46 Million	52,249	52,249 $2.46 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Exact Sciences Corp Transaction History